Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 495 - Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
Patents for C07D 495 - Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms (21,336)
06/2010
06/03/2010WO2010060389A1 A method for the manufacture of highly pure prasugrel
06/03/2010WO2010014236A3 Acylhydrazone-based cleavable linkers
06/03/2010WO2009154300A3 Heterocyclic compound and use thereof
06/03/2010WO2009053715A8 Thienopyrimidiene derivatives as pi3k inhibitors
06/03/2010US20100137617 Method for producing aromatic compound
06/03/2010US20100137585 Fused heteroaryl derivatives
06/03/2010US20100137584 Fused heteroaryl derivatives
06/03/2010US20100137581 Process for preparation of substantially pure polymorphic form i of olanzapine
06/03/2010US20100137397 Chemical Compounds
06/03/2010US20100137329 Derivatives of 1-piperazine- and 1-homopiperazine-carboxylates, preparation method thereof and use of same as inhibitors of the faah enzyme
06/03/2010US20100137298 Biaryl Sulfonamides and Methods for Using Same
06/03/2010US20100137281 Heterocyclic compound and use thereof
06/03/2010US20100137274 Rivaroxaban and derivatives, synthesis; atherosclerosis; arthritis; Alzheimer's disease or cancer
06/03/2010US20100137270 Modulation of prostaglandin/cyclooxygenase metabolic pathways
06/03/2010US20100136538 Marking reagents bearing diazo and nitro functions, methods for the synthesis of such reagents and methods for detecting biological molecules
06/02/2010EP2192123A1 Fused tricyclic compounds useful in organic thin film devices such as transistors
06/02/2010EP2192122A1 Dithiolopyrrolone compounds, the preparation and the use thereof
06/02/2010EP2190843A1 Benzimidazole nf- kappab inhibitors
06/02/2010EP1745040B9 Azabicyclo(3.1.0) hexane derivatives useful as modulators of dopamine d3 receptors
06/02/2010CN101717630A Hole transmission material for enhancing hole transmission capacity and preparation method thereof
06/02/2010CN101717403A New green synthesizing process for ketocoumaran compound
06/01/2010US7727997 N,N′-substituted-1,3-diamino-2-hydroxypropane derivatives
06/01/2010US7727933 used as pesticides and/or pre- or postemergence herbicides
06/01/2010CA2448737C Viral polymerase inhibitors
06/01/2010CA2409827C Arylmethylamine derivatives for use as tryptase inhibitors
05/2010
05/27/2010WO2010058833A1 Novel heterocyclic compound and use thereof
05/27/2010WO2010058692A1 Novel compound, process for producing the compound, organic semiconductor material, and organic semiconductor device
05/27/2010US20100130541 Processes for the preparation of clopidogrel
05/27/2010US20100130514 Fused heterocyclic derivative, pharmaceutical composition comprising the derivative, and use of the composition for medical purposes
05/27/2010US20100130481 Anticonvulsant and anxiolytic methods of using receptor subtype selective agents
05/26/2010EP2188295A2 Pyridine derivatives and methods of use thereof
05/26/2010EP1951730B1 Heteroalkyl linked pyrimidine derivatives
05/26/2010CN1649883B Bicyclic 6-alkylidene-penems as lactamases inhibitors
05/26/2010CN1642580B Radiolabelled quinoline and quinolinone derivatives and their use as metabotropic glutamate receptor ligands
05/26/2010CN101715442A Heterocyclic aspartyl protease inhibitors
05/26/2010CN101712660A Derivatives of piperidinyl- and piperazinyl-alkyl carbamates, preparation methods thereof and application of same in therapeutics
05/25/2010US7723523 Tetrahydropyridothiophenes
05/25/2010US7723450 polymerization catalyst having a cyclopenta[b]benzothienylidene groups for preparing polyethylene or ethylene-hexane copolymer; alumoxane cocatalyst; broad molecular weight distribution
05/25/2010US7723331 Thienopyrimidine compounds and uses thereof
05/25/2010CA2522734C New polymorphs of olanzapine hydrochloride
05/20/2010WO2010057141A2 Alphavirus inhibitors and uses thereof
05/20/2010WO2010056875A1 Pyridazinones and their use as btk inhibitors
05/20/2010WO2010054961A1 Spiro-5,6-dihydro-4h-2,3,5,10b-tetraaza-benzo[e]azulenes
05/20/2010WO2010027567A3 Tricyclic spirocycle derivatives and methods of use thereof
05/20/2010US20100123124 Organic thin-film transistors
05/20/2010US20100123123 Organic thin-film transistors
05/20/2010CA2741018A1 Spiro-5,6-dihydro-4h-2,3,5,10b-tetraaza-benzo[e]azulenes
05/19/2010EP2186803A2 Substituted thioacetamides
05/19/2010EP2185566A2 Process for the purification of olanzapine
05/19/2010EP1682553B1 Thienopyrazoles
05/19/2010CN101195629B D-biotin purification process
05/19/2010CN101121720B Method for preparing clopidogrel hydrogen shlfate
05/18/2010US7718665 10-(o-Hydroxyphenyl)--3a,4,9,10-tetrahydro-2-alkyl-2,9,10a-triazacyclopenty[b]fluorene-1,3-diones or the corresponding 2,10a-diaza-9 oxafluorenediones or 1,10a-diaza-9-thiafluorenediones; antiproliferative, apoptosis-inducing agents; treating color cancer
05/18/2010CA2422371C Pyrazole compounds useful as protein kinase inhibitors
05/18/2010CA2422367C Pyrazole compounds useful as protein kinase inhibitors
05/18/2010CA2355716C Benzisoxazoles and phenones as .alpha.2-antagonists
05/14/2010WO2010054285A2 Fused bicyclic and tricyclic pyrimidine compounds as tyrosine kinase inhibitors
05/14/2010WO2010053438A1 Modulators of amyloid beta.
05/14/2010CA2742897A1 Modulators of amyloid beta.
05/14/2010CA2741990A1 Triazine, pyrimidine and pyridine analogs and their use as therapeutic agents and diagnostic probes
05/13/2010US20100120884 Use of dithiine-tetracarboximides for controlling phytopathogenic fungi
05/13/2010US20100120805 Fused Bicyclic and Tricyclic Pyrimidine Compounds as Tyrosine Kinase Inhibitors
05/13/2010US20100120789 Compound
05/13/2010US20100120767 Pyrimidothiophene Compounds
05/13/2010US20100117066 Organic Semiconductors
05/13/2010US20100116655 Chemical messenger sensor
05/12/2010EP2183255A1 Processes and intermediates for preparing fused heterocyclic kinase inhibitors
05/12/2010EP2183254A1 Inhibitors of protein tyrosine kinase activity
05/12/2010EP2183253A1 Thieno-pyridine derivatives as mek inhibitors
05/12/2010EP2183239A1 Sulfonamides as trpm8 modulators
05/12/2010DE202007019054U1 Spiraprilhydrochlorid und polymorphe Formen davon Spirapril hydrochloride and polymorphic forms thereof
05/12/2010CN1938319B Crystalline clopidogrel naphthalenesulfonate or hydrate thereof, method for preparing same and pharmaceutical composition containing same
05/12/2010CN101161656B Dibenzo tetrathiafulvalene tetracarbonyl imide derivative and preparation method and uses thereof
05/11/2010US7714134 Compounds and use of tetrahydropyridothiophenes
05/11/2010US7714133 alpha-(2-chlorophenyl)-6,7dihydrothieno[3,2-c]pyridine-5(4H)-acetic acid methyl ester (clopidogrel hydrogen sulphate); separating crystalline form out of a solution of clopidogrel in the form of the free base in a 2-propanol or n-butyl acetate solvent by adding sulphuric acid
05/11/2010US7714098 Mono-, oligo- and polythieno[3,2-b]thiophenes
05/11/2010US7714018 Heterocyclic antiviral compounds
05/11/2010US7713963 Acylated indanyl amines and their use as pharmaceuticals
05/11/2010CA2422299C Triazole compounds useful as protein kinase inhibitors
05/11/2010CA2415532C Novel 4-phenyl substituted tetrahydroisoquinolines therapeutic use thereof
05/11/2010CA2326324C Nitrogen-containing heterocyclic compound
05/11/2010CA2223261C Improved delivery of diagnostic and therapeutic agents to a target site
05/06/2010WO2010050779A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same
05/06/2010WO2010049466A1 Thienotriazolodiazepine derivatives active on apo a
05/06/2010WO2010029577A3 Anti-cancer drugs and uses relating thereto for metastatic malignant melanoma and other cancers
05/06/2010US20100113485 Piperidinylamino-thieno[2,3-D] Pyrimidine Compounds
05/06/2010US20100113484 Treating agent of uropathy
05/06/2010US20100113421 Non-nucleoside reverse transcriptase inhibitors
05/06/2010US20100113410 Pyrazolopyrimidine derivative
05/06/2010US20100112090 Nitrogenated fused ring derivative, pharmaceutical composition comprising the same, and use of the same for medical purposes
05/06/2010CA2741934A1 Thienotriazolodiazepine derivatives active on apo a
05/05/2010EP1474147B1 Pyrimidine-based compounds useful as gsk-3 inhibitors
05/05/2010CN1939923B Production of dozoan intermediate
05/05/2010CN1706839B Material containing non-benzenoid aryl spiro and its synthesis and application
05/05/2010CN101701020A Amide derivate, preparation method and application thereof
05/04/2010US7709478 Acylated 6,7,8,9-tetrahydro-5H-benzocycloheptenyl amines and their use as pharmaceutical agents
05/04/2010CA2427608C Condensed pyradizindione derivatives as pde inhibitors
05/04/2010CA2385817C Substituted pyridines and pyridazines with angiogenesis inhibiting activity
04/2010
04/29/2010WO2010046852A1 Process for the preparation of clopidogrel hydrogen sulphate form 1
04/29/2010WO2010046639A1 Fused pyridine derivatives as kinase inhibitors
1 ... 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 ... 214